Stage‐specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy
- 12 September 2012
- journal article
- research article
- Published by Wiley in International Journal of Urology
- Vol. 20 (4) , 390-397
Abstract
Objectives: To evaluate the impact of an extended versus a standard pelvic lymph node dissection on disease‐free survival and cancer‐specific survival of patients with non‐metastatic muscle‐invasive urothelial carcinoma of the bladder treated with radical cystectomy.Methods: We retrospectively analyzed data of 933 patients collected in two prospectively‐maintained institutional databases between 2002 and 2010. Patients who met inclusion criteria (high‐grade urothelial carcinoma, have not undergone neoadjuvant treatments, have not undergone salvage cystectomy) were included for analysis. The upper boundary was the iliac bifurcation for standard lymph‐node dissection and the aortic bifurcation for the extended lymph node dissection, respectively. Univariable and multivariable Cox regression analyses were carried out to identify independent predictors of disease‐free survival and cancer‐specific survival and, subsequently, the effect of extended lymph node dissection was determined with a multivariable Cox analysis after stratifying for significant covariates.Results: At multivariable analysis, once adjusted for the effect of the other covariates, extended lymph node dissection was an independent predictor of disease‐free survival (hazard ratio 1.95, P < 0.001) and cancer‐specific survival (hazard ratio 1.80, P < 0.001). The benefit of an extended pelvic lymph node dissection on disease‐free survival and cancer‐specific survival was significant across all pT stages (all P < 0.05) except for pT P = 0.011 and P = 0.034 for disease‐free survival and cancer‐specific survival, respectively; pN1 and pN2, all P < 0.001).Conclusions: The staging accuracy and the survival benefit provided by extended pelvic lymph node dissection suggests the adoption of this template as the standard template for patients with muscle‐invasive urothelial carcinoma of the bladder undergoing radical cystectomy.Keywords
This publication has 12 references indexed in Scilit:
- Development and external validation of lymph node density cut‐off points in prospective series of radical cystectomy and pelvic lymph node dissectionInternational Journal of Urology, 2012
- Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative StudyJournal of Urology, 2011
- Stage‐specific impact of pelvic lymph node dissection on survival in patients with non‐metastatic bladder cancer treated with radical cystectomyBJU International, 2011
- Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trialAnnals of Oncology, 2011
- Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU GuidelinesEuropean Urology, 2011
- Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node‐negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trialBJU International, 2010
- How Do Commonly Performed Lymphadenectomy Templates Influence Bladder Cancer Nodal Stage?Journal of Urology, 2010
- Trends in Pelvic Lymphadenectomy at the Time of Radical Cystectomy: 1988 to 2004Journal of Urology, 2009
- LYMPH NODE INVOLVEMENT IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A PATHO-ANATOMICAL STUDY—A SINGLE CENTER EXPERIENCEJournal of Urology, 2004
- Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group ReportJournal of Urology, 2004